Efficacy and Safety of Doxepin 3 and 6 mg in a 35-day Sleep Laboratory Trial in Adults with Chronic Primary Insomnia

STUDY OBJECTIVES: To evaluate the efficacy and safety of doxepin (DXP) 3 mg and 6 mg in adults diagnosed with primary insomnia. DESIGN AND METHODS: The study was a randomized, double-blind, parallel-group, placebo-controlled trial. Patients meeting DSM-IV-TR criteria for primary insomnia were random...

Full description

Saved in:
Bibliographic Details
Main Authors: Krystal, Andrew D., Lankford, Alan, Durrence, H. Heith, Ludington, Elizabeth, Jochelson, Philip, Rogowski, Roberta, Roth, Thomas
Format: Artigo
Language:Inglês
Published: Associated Professional Sleep Societies, LLC 2011
Subjects:
Efficacy and Safety of Doxepin in Adults with Chronic Insomnia
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3174845/
https://ncbi.nlm.nih.gov/pubmed/21966075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5665/SLEEP.1294
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items